Concourse Financial Group Securities’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-200
Closed -$12.2K 2448
2023
Q1
$12.8K Sell
200
-619
-76% -$40.4K ﹤0.01% 1593
2022
Q4
$39.8K Sell
819
-68
-8% -$4.26K ﹤0.01% 1179
2022
Q3
$63K Buy
887
+24
+3% +$2.05K 0.01% 874
2022
Q2
$61K Sell
863
-81
-9% -$5.22K 0.01% 1006
2022
Q1
$75K Buy
+944
New +$70.3K 0.01% 983
2021
Q4
Sell
-312
Closed -$33.5K 2471
2021
Q3
$40K Buy
312
+63
+25% +$8.82K ﹤0.01% 1411
2021
Q2
$38K Buy
+249
New +$32.8K ﹤0.01% 1424
2020
Q3
Sell
-132
Closed -$7.11K 2253
2020
Q2
$8K Buy
132
+58
+78% +$2.37K ﹤0.01% 1560
2020
Q1
$2K Buy
+74
New +$2.49K ﹤0.01% 1930

Other funds holding STAA

Concourse Financial Group Securities's STAA Position: Q2 2023 in Review

Concourse Financial Group Securities sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 200 shares — an estimated $12.2K sold.

Concourse Financial Group Securities first reported a position in STAA in Q1 2020 and held it in 9 quarters. The position peaked at $75K in Q1 2022. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Concourse Financial Group Securities reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Concourse Financial Group Securities sold 200 STAAR Surgical shares in Q2 2023, an estimated $12.2K.
  • Concourse Financial Group Securities first reported a position in STAAR Surgical in Q1 2020 and held it in 9 quarters.
  • Concourse Financial Group Securities's STAAR Surgical position peaked at $75K in Q1 2022.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Concourse Financial Group Securities's 13F filing for Q2 2023, filed 10 Aug 2023.